Although the terms brain pliability, brain plasticity, and neuroplasticity are closely tied to the 20th century, the concepts ...

Combining the physical significance of theoretical models with the high fitting accuracy of data-driven models is crucial for precise characterization of fuel cell electric truck (FCET) energy ...

Glioblastoma (GBM), a highly aggressive brain tumor, presents significant treatment challenges due to the lack of targeted therapies. Aptamers offer a promising solution, with their small size and ...

The biotech bi-weekly: unveiling a single-cell RNA-sequencing kit, scaling up a cell-based mRNA design platform and introducing an optogenetic screening platform for drug discovery 16 Jul 2025 Written ...

The Langlands programme has inspired and befuddled mathematicians for more than 50 years. A major advance has now opened up new worlds for them to explore.

Tevogen.AI has launched PredicTcell™, reducing drug discovery timelines and costs, and expanding into oncology for cancer research.

A landmark study published in Cell has unveiled a first-of-a-kind optogenetic screening platform, developed by scientists at Integrated Biosciences. The Cell paper demonstrates the platform&rsquo ...

Recent advances in spatial omics and single-cell omics have significantly reshaped biomarker discovery in tumor immunotherapy by addressing critical challenges posed such as tumor heterogeneity ...

Breast cancer stem cells (BCSCs) are pivotal in tumor initiation, progression, and therapeutic resistance, underscoring the need for targeted interventions. Signal transducer and activator of ...

A giant gas planet comparable in size to Saturn exists around a small red dwarf star. The discovery is beyond the scope of conventional astronomy theory, and is making experts reconsider ...

New discovery in small primate could pave the way for im-proved stem cell therapies For the first time, researchers have discovered and isolated adult stem cells from a non-human primate.

E3 ligase speckle-type POZ protein (SPOP) is a potential therapeutic target in clear-cell renal cell carcinoma (ccRCC). However, small-molecule inhibitors targeting SPOP are rarely reported. Here, we ...